UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1693) 1693
science & technology (1579) 1579
life sciences & biomedicine (1476) 1476
erlotinib hydrochloride (1287) 1287
oncology (1004) 1004
erlotinib (763) 763
quinazolines - pharmacology (734) 734
lung neoplasms - drug therapy (722) 722
female (716) 716
receptor, epidermal growth factor - antagonists & inhibitors (630) 630
carcinoma, non-small-cell lung - drug therapy (615) 615
cell line, tumor (594) 594
male (591) 591
animals (552) 552
protein kinase inhibitors - pharmacology (550) 550
biological and medical sciences (547) 547
medical sciences (542) 542
quinazolines - therapeutic use (491) 491
middle aged (469) 469
antineoplastic agents - pharmacology (455) 455
tumors (453) 453
aged (441) 441
receptor, epidermal growth factor - genetics (400) 400
mice (391) 391
lung neoplasms - pathology (377) 377
pharmacology & pharmacy (375) 375
pharmacology. drug treatments (364) 364
antineoplastic agents (358) 358
antineoplastic agents - therapeutic use (355) 355
mutation (355) 355
receptor, epidermal growth factor - metabolism (351) 351
quinazolines - administration & dosage (344) 344
protein kinase inhibitors - therapeutic use (342) 342
cancer (337) 337
adult (334) 334
erlotinib hydrochloride - pharmacology (326) 326
lung neoplasms - genetics (326) 326
epidermal growth factor (313) 313
carcinoma, non-small-cell lung - pathology (292) 292
lung cancer (290) 290
treatment outcome (271) 271
antineoplastic combined chemotherapy protocols - therapeutic use (267) 267
carcinoma, non-small-cell lung - genetics (261) 261
lung cancer, non-small cell (257) 257
cell proliferation - drug effects (239) 239
egfr (228) 228
chemotherapy (224) 224
gefitinib (210) 210
respiratory tract diseases (209) 209
lung neoplasms - metabolism (208) 208
quinazolines - adverse effects (206) 206
care and treatment (204) 204
tyrosine (202) 202
xenograft model antitumor assays (198) 198
analysis (195) 195
aged, 80 and over (194) 194
drug resistance, neoplasm (192) 192
mice, nude (192) 192
signal transduction - drug effects (192) 192
apoptosis - drug effects (186) 186
pneumology (186) 186
tumors of the respiratory system and mediastinum (184) 184
research (181) 181
erbb receptors - antagonists & inhibitors (179) 179
epidermal growth factor receptor (172) 172
signal transduction (162) 162
disease-free survival (157) 157
kinases (155) 155
carcinoma, non-small-cell lung - metabolism (152) 152
antibodies, monoclonal, humanized (149) 149
non-small cell lung cancer (146) 146
erlotinib hydrochloride - therapeutic use (145) 145
adenocarcinoma - drug therapy (144) 144
drug synergism (144) 144
neoplasms (144) 144
dose-response relationship, drug (141) 141
cell biology (140) 140
medicine & public health (140) 140
epidermal growth factor receptors (136) 136
cetuximab (129) 129
apoptosis (128) 128
erlotinib hydrochloride - administration & dosage (128) 128
protein kinase inhibitors - administration & dosage (127) 127
drug therapy (126) 126
drug resistance, neoplasm - genetics (121) 121
health aspects (121) 121
pharmacology/toxicology (121) 121
drug resistance, neoplasm - drug effects (119) 119
phosphorylation (113) 113
quinazolines - pharmacokinetics (113) 113
antineoplastic agents - administration & dosage (112) 112
cancer research (111) 111
deoxycytidine - analogs & derivatives (111) 111
erbb receptors - genetics (111) 111
cell survival - drug effects (110) 110
genetic aspects (108) 108
protein kinase inhibitors - adverse effects (107) 107
erbb receptors - metabolism (106) 106
pancreatic neoplasms - drug therapy (105) 105
antineoplastic agents - adverse effects (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1820) 1820
Chinese (10) 10
Russian (6) 6
French (5) 5
Japanese (5) 5
Hungarian (4) 4
German (3) 3
Spanish (2) 2
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of pharmaceutical and biomedical analysis, ISSN 0731-7085, 09/2018, Volume 158, pp. 174 - 183
Therapeutic drug monitoring | Tyrosine kinase inhibitor | LC–MS/MS | Lung cancer | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Chemistry, Analytical | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Chromatography, High Pressure Liquid | Drug Monitoring - methods | Tandem Mass Spectrometry | Pyrazoles - blood | Sensitivity and Specificity | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Piperazines - blood | Pyrazoles - pharmacology | Pyridines - therapeutic use | Crizotinib | Limit of Detection | Reproducibility of Results | ErbB Receptors - antagonists & inhibitors | Drug Stability | Indoles - blood | Piperazines - therapeutic use | Piperazines - pharmacology | Protein Kinase Inhibitors - blood | Quinazolines - blood | Erlotinib Hydrochloride - blood | Pyridines - blood | Afatinib | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Erlotinib Hydrochloride - pharmacology | Antineoplastic Agents - blood | Carcinoma, Non-Small-Cell Lung - blood | Indoles - therapeutic use | Erlotinib Hydrochloride - therapeutic use | Lung Neoplasms - blood | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Quinazolines - pharmacology | Tyrosine | Lung cancer, Small cell | Liquid chromatography | Lung cancer, Non-small cell | Antineoplastic agents | Antimitotic agents | Epidermal growth factor | Erlotinib | Analysis | Formic acid | Nitriles | Lymphomas | Precipitation (Meteorology) | Health aspects | Mass spectrometry | Vascular endothelial growth factor | Index Medicus
Journal Article
Molecular pharmaceutics, ISSN 1543-8384, 03/2019, Volume 16, Issue 3, pp. 1282 - 1293
blood-brain barrier | P-glycoprotein | tyrosine kinase inhibitors | breast cancer resistance protein | C]erlotinib | [ | positron emission tomography | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Capillary Permeability - physiology | Quinolines - blood | ATP Binding Cassette Transporter, Subfamily G, Member 2 - metabolism | Cyclosporine - pharmacology | Quinolines - administration & dosage | Quinolines - pharmacology | Brain - metabolism | Cyclosporine - blood | Tissue Distribution | Radiopharmaceuticals - metabolism | Drug Interactions | Female | Models, Animal | ATP Binding Cassette Transporter, Subfamily G, Member 2 - antagonists & inhibitors | Cyclosporine - metabolism | Radiopharmaceuticals - pharmacology | Erlotinib Hydrochloride - administration & dosage | Solubility | Positron-Emission Tomography - methods | Protein Kinase Inhibitors - blood | Blood-Brain Barrier - metabolism | Erlotinib Hydrochloride - blood | Radiopharmaceuticals - blood | Quinolines - metabolism | Radiopharmaceuticals - administration & dosage | ATP Binding Cassette Transporter, Subfamily B, Member 1 - antagonists & inhibitors | ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism | Protein Kinase Inhibitors - administration & dosage | Animals | Erlotinib Hydrochloride - pharmacology | Cyclosporine - administration & dosage | Erlotinib Hydrochloride - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Protein Kinase Inhibitors - metabolism | Index Medicus
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 04/2019, Volume 14, Issue 4, pp. 641 - 655
Journal Article
Nature (London), ISSN 0028-0836, 03/2012, Volume 483, Issue 7387, pp. 100 - 104
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Chemotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - agonists | Apoptosis - drug effects | Colorectal Neoplasms - genetics | Humans | Antineoplastic Agents - therapeutic use | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | RNA Interference | Colorectal Neoplasms - drug therapy | HEK293 Cells | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Cetuximab | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Melanoma - metabolism | Colorectal Neoplasms - enzymology | Antibodies, Monoclonal - pharmacology | Enzyme Activation - drug effects | Sulfonamides - pharmacology | Drug Synergism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Quinazolines - therapeutic use | Melanoma - drug therapy | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Feedback, Physiological - drug effects | Indoles - therapeutic use | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Colorectal Neoplasms - pathology | Quinazolines - pharmacology | Drug Resistance, Neoplasm - drug effects | Proteins | Library collections | Studies | Phosphorylation | Kinases | Index Medicus
Journal Article
Journal Article
Journal Article